TFA Therapeutics (RAJAF) Other Non-Current Assets (2021 - 2025)

TFA Therapeutics has reported Other Non-Current Assets for 5 years, with the latest figure at $13771.0 in Q4 2025.

• On a quarterly basis, Other Non-Current Assets rose 4.52% year-over-year to $13771.0 in Q4 2025; TTM through Dec 2025 was $13771.0, a 4.52% increase from a year earlier, with the FY2025 full-year figure at $13771.0, up 4.52% from the prior year.
• Other Non-Current Assets was $13771.0 for Q4 2025 at TFA Therapeutics, up from $13175.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $1.3 million in Q4 2022, with the low at $197.0 in Q4 2021.
• Average Other Non-Current Assets over 5 years is $437922.2, with a median of $13918.5 recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets soared 684988.83% in 2022, then sank 98.96% in 2023.
• Over 5 years, Other Non-Current Assets stood at $197.0 in 2021, then jumped by 684988.83% to $1.3 million in 2022, then tumbled by 98.96% to $14066.0 in 2023, then slipped by 6.33% to $13175.0 in 2024, then gained by 4.52% to $13771.0 in 2025.
• The last three Other Non-Current Assets figures came in at $13771.0 (Q4 2025), $13175.0 (Q4 2024), and $14066.0 (Q4 2023), per Business Quant data.